AI summary · may contain errors
A modified Delphi consensus in primary biliary cholangitis (PBC) reached agreement on 16 statements and 42 recommendations, with 62 international panelists and 88% then 60% voting response rates.
- Open access
- 13 cites
Moving in Journal of Hepatology.
Rebuilt
AI summary · may contain errors
A modified Delphi consensus in primary biliary cholangitis (PBC) reached agreement on 16 statements and 42 recommendations, with 62 international panelists and 88% then 60% voting response rates.
Newest first · last 60 days
AI summary · may contain errors
MAIT cells drive early fibrogenesis in the carbon tetrachloride mouse model, exacerbating myofibroblast activation and matrix deposition during fibrosis initiation.
AI summary · may contain errors
Aquitalea magnusonii translocation across the intestinal barrier is linked to systemic inflammation and liver fibrosis in chronic liver disease models, including ACLF-associated metabolite production.
AI summary · may contain errors
One year of elafibranor normalized alkaline phosphatase in phase III ELSPIRE trial patients with primary biliary cholangitis who had incomplete response to ursodeoxycholic acid, targeting ALP ≤ULN (≤120 U/L).
AI summary · may contain errors
The AGA/AASLD guideline for adults with primary biliary cholangitis agrees on 6 evidence-based recommendations spanning diagnosis, risk assessment, treatment escalation, pruritus control, and post-transplant prevention.
AI summary · may contain errors
Cholangiocarcinomas show biologically distinct molecular subtypes that are not aligned with intrahepatic, perihilar, and distal surgical categories, including actionable targets like FGFR2 fusions and IDH1/2 mutations.
AI summary · may contain errors
A European-ancestry GWAS of 2366 cholangiocarcinoma cases and 11,750 controls identifies a new genome-wide significant variant, rs535777 (OR=1.44), near HLA-DRB1/DQA1.
AI summary · may contain errors
Myeloid CD36 deficiency in fibrotic mouse livers promotes macrophage adaptive immunity, linked to restored MHC-I antigen presentation and CD8+ T cell activation.
AI summary · may contain errors
K. pneumoniae-derived outer membrane vesicles aggravate primary sclerosing cholangitis in Mdr2(-/-) mice, increasing cholestatic liver injury, fibrosis, and bile duct hyperplasia.
AI summary · may contain errors
Fibrosis regression in chronic liver disease can substantially disappear or be remodelled, and even established cirrhosis reversal has been documented, but clinical significance of regressive histology remains largely unstudied.
AI summary · may contain errors
Advanced liver fibrosis and At-Risk MASH occur in 5% and 10%, respectively, of community patients with steatotic liver disease plus metabolic risk factors and/or excess alcohol consumption.
AI summary · may contain errors
In HER2-positive advanced biliary tract cancer, a first-line trastuzumab+nivolumab plus gemcitabine/cisplatin regimen achieved a 55% objective response rate among 40 participants.
AI summary · may contain errors
The liver integrates gut microbiome, nutrients, drugs, and toxins to regulate immune responses and antigen modification, shaping autoimmune rheumatic disease pathogenesis through metabolite and cytokine control.
AI summary · may contain errors
Saroglitazar 0.97 mg improved biochemical response in 148 patients with primary biliary cholangitis at week 52, reaching 56.7% versus 9.8% with placebo.
AI summary · may contain errors
Drinking-water 4,4'-methylenedianiline (MDA) in male C57BL/6JJcl mice produces sustained ALT elevation with no observed mortality and stronger cholestatic biochemistry than TAA-DW.
AI summary · may contain errors
AASLD/AGA guideline for adults with primary biliary cholangitis agrees on six evidence-based recommendations, including UDCA first-line therapy and linerixibat for moderate-to-severe pruritus.
AI summary · may contain errors
RPL4 knockdown enhances anti-PD-L1 immunotherapy efficacy in FBXL6-driven liver fibrosis in mice, improving therapeutic performance against activated hepatic stellate cell–driven disease.
Journals this month
Topics moving, week to 17 Nov 2026
By field